Daily as of 3 Nov 16:00 ET
- Price
- above both $35.14 vs 50 $34.27 / 200 $28.47
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 15 Sep 2026 · projected 29 bars out
CSTL | Castle BiosciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$35.14
+$0.20 (+0.57%)
Castle Biosciences (CSTL) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
The 50 SMA has sat above the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $37.16 vs 50 $30.23 / 200 $24.31
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 29 Dec 2025 · projected 11 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $35.14 vs 50 $34.33 / 200 $30.16
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 23 Jul 2026 bar 2 · projected 21 bars out · tested 3 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 15 Sep 2026 | 🟨Golden steep | daily | 29 bars out | Not tested |
| 23 Jul 2026 | 🟨Golden | 4-hour | 21 bars out | 3 bar cross test |
| 15 Apr 2026 | 💀Death steep | daily | 30 bars out | Not tested |
| 2 Mar 2026 | 💀Death | 4-hour | 27 bars out | Not tested |
| week of 29 Dec 2025 | 🟨Golden flat | weekly | 11 bars out | Not tested |
About CSTL
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$11.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandsmall